Comparing a new antibiotic to standard polymyxin B in healthy people
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a new version of an antibiotic (called VRP-034) is safe and how it affects the kidneys compared to the standard version. It's for healthy volunteers to gather initial safety information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy man between 18 and 45 years old.
- Have a healthy weight (BMI 18.5–28) and weigh at least 110 pounds (50 kg).
- Have normal kidney function (creatinine clearance of 90 mL/min or higher).
- Not have G6PD deficiency (a red blood cell condition).
- Not smoke or drink alcohol regularly.
- Be free of any major medical conditions like heart, liver, or kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug (BMS-986521) in healthy volunteers to see how safe it is and how the body processes it. It helps researchers decide if the drug can be tested in future studies.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This trial tests how two experimental drugs, IN-M00007 and IN-R00007, move through the body and how safe they are. It is for healthy adults to gather basic information before testing in patients.
This early-stage study tests how a new drug called BV100 affects how your body processes polymyxin B, an antibiotic. Researchers want to understand how these two drugs interact so they can develop safer treatments.
This study compares an experimental antibiotic called ASK0912 with an approved antibiotic (polymyxin B) in adults with hospital-acquired or ventilator-associated pneumonia. It aims to see if the new drug is as effective and safe as the standard treatment.
This study tests an experimental antibiotic called BWC0977 to see if it is safe and well-tolerated when given as single and multiple doses. It is for healthy volunteers to understand how the drug behaves in the body before moving to patient trials.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.